Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Marijuana Abuse × CNS × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 239 Glioblastoma 209 Glioma 167 Neuroblastoma 69 Neoplasms 43 Central Nervous System Neoplasms 42 Astrocytoma 41 Meningioma 39 Medulloblastoma 37 Carcinoma, Non-Small-Cell Lung 33 Ependymoma 31 Breast Neoplasms 31 Neurofibromatosis 1 30 Melanoma 27 Lung Neoplasms 26 Sarcoma 23 Diffuse Intrinsic Pontine Glioma 22 Osteosarcoma 21 Neoplasm Metastasis 20 Recurrence 19 Oligodendroglioma 19 Pheochromocytoma 18 Gliosarcoma 18 Rhabdoid Tumor 17 Sarcoma, Ewing 16 Paraganglioma 16 Rhabdomyosarcoma 15 Neurofibroma, Plexiform 14 Meningeal Carcinomatosis 14 Pancreatic Neoplasms 13

Interventions

nabiximols 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05629702 2026-01-30

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡